Sponsor study identifier
interventional
56
1 country
1
Study Start
June 1, 2023
Actual (reported)Primary Completion
December 31, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
December 31, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
This is a randomized controlled study to assess the effect of choline fenofibrate compared with policosanol in Korean T2DM patients with asymptomatic atherosclerosis.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 31, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 16, 2022
Actual (reported)May 9, 2022
Actual (reported)June 1, 2023
Actual (reported)December 31, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
December 31, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Carotid intima media thickness
Maximum carotid IMT (mm)
24 week
Area of carotid artery plaque
24 week
Plaque characteristics
24 week
Glucose homeostasis
24 week
Lipid metabolism
24 week
Bioelectrical Impedance Analysis
24 week
Choline fenofibrate (135mg as fenofibric acid) 1 tablet once daily oral administration regardless of diet
Policosanol 10mg 1 tablet once daily oral administration
choline fenofibrate 178.8mg (135mg as fenofibric acid)
policosanol 10mg
SNUBH
Seongnam-si, Gyeonggi-do, 13620, South Korea
First Submitted
March 16, 2022
First Posted
May 9, 2022
Study Start
June 1, 2023
Actual (reported)Primary Completion
December 31, 2026
EstimatedRegistry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
December 31, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
May 5, 2026
Record last verified: 2026-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: